Nova Eye Medical Limited (ASX:EYE)
0.1450
+0.0100 (7.41%)
Apr 28, 2026, 4:10 PM AEST
Nova Eye Medical Market Cap
Nova Eye Medical has a market cap or net worth of 41.3 million as of April 28, 2026. Its market cap has increased by 32.17% in one year.
Market Cap
41.30M
Enterprise Value
41.47M
Revenue
33.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since March 9, 1998, Nova Eye Medical's market cap has increased from 785.81K to 41.30M, an increase of 5,155.94%. That is a compound annual growth rate of 15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 38.45M | 1.89% |
| Dec 31, 2025 | 37.74M | 2.97% |
| Dec 31, 2024 | 36.65M | -19.89% |
| Dec 29, 2023 | 45.75M | 12.00% |
| Dec 29, 2022 | 40.85M | -17.46% |
| Dec 31, 2021 | 49.49M | -2.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 93.07M |
| Compumedics | 56.93M |
| HeraMED | 56.59M |
| Micro-X | 39.24M |
| CleanSpace Holdings | 34.33M |
| ImpediMed | 28.54M |
| CurveBeam AI | 28.19M |
| Control Bionics | 24.72M |